ALLIQUA BIOMEDICAL INC's ticker is ALQA and the CUSIP is 019621200. A total of 31 filers reported holding ALLIQUA BIOMEDICAL INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $164,000 | -1.8% | 450,000 | 0.0% | 0.01% | -11.1% |
| Q2 2017 | $167,000 | -26.4% | 450,000 | 0.0% | 0.01% | -18.2% |
| Q1 2017 | $227,000 | -28.8% | 450,000 | -16.7% | 0.01% | -47.6% |
| Q4 2016 | $319,000 | -26.2% | 540,000 | 0.0% | 0.02% | -12.5% |
| Q3 2016 | $432,000 | -28.6% | 540,000 | 0.0% | 0.02% | -25.0% |
| Q2 2016 | $605,000 | +18.6% | 540,000 | -13.1% | 0.03% | 0.0% |
| Q1 2016 | $510,000 | -71.0% | 621,429 | -24.5% | 0.03% | -82.3% |
| Q4 2015 | $1,760,000 | -53.2% | 822,549 | -30.6% | 0.18% | -43.8% |
| Q3 2015 | $3,759,000 | -41.8% | 1,185,676 | -3.3% | 0.32% | -17.9% |
| Q2 2015 | $6,462,000 | +9.8% | 1,226,176 | +8.3% | 0.39% | +7.7% |
| Q1 2015 | $5,887,000 | -6.6% | 1,132,193 | -4.8% | 0.36% | -51.3% |
| Q4 2014 | $6,306,000 | +56.9% | 1,189,800 | +43.6% | 0.75% | +207.4% |
| Q3 2014 | $4,018,000 | +1.4% | 828,487 | +15.0% | 0.24% | -16.2% |
| Q2 2014 | $3,964,000 | -7.8% | 720,687 | +41.3% | 0.29% | -8.5% |
| Q1 2014 | $4,299,000 | – | 510,000 | – | 0.32% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 784,594 | $6,472,000 | 0.68% |
| J. Goldman & Co LP | 510,000 | $4,299,000 | 0.32% |
| SUFFOLK CAPITAL MANAGEMENT LLC | 186,287 | $1,570,000 | 0.20% |
| JHL Capital Group LLC | 80,000 | $674,000 | 0.05% |
| Edge Wealth Management LLC | 4,930 | $42,000 | 0.02% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 5,000 | $42,000 | 0.01% |
| MILLENNIUM MANAGEMENT LLC | 100,000 | $843,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 1,671 | $14,000 | 0.00% |
| Family Capital Trust Co | 200 | $2,000 | 0.00% |
| MORGAN STANLEY | 5,979 | $50,000 | 0.00% |